Back

Native T1 is independently predictive of aerobic functional capacity by VO2max in long-term follow-up of individuals with mild initial COVID disease.

30 August 2025 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Mapping and function in cardiac magnetic resonance T1 and T2 Mapping ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Monika Rozewicz-Juraszek

University Hospital Schleswig-Holstein, Kiel (Germany)

6 More presentations in this session

Presentation thumbnail
Left ventricular global longitudinal strain adds incremental value for risk prediction in an all-comer low-risk real-world clinical patient population
Doctor S. Backhaus (Bad Nauheim, DE)
Abstract Slides Video
Presentation thumbnail
Age, sex and ethnicity-stratified myocardial strain reference ranges from the healthy hearts consortium
Doctor J. Salatzki (Heidelberg, DE)
Abstract Slides Video
Presentation thumbnail
Multicenter cardiovascular magnetic resonance reference ranges and severity grading for ventricular and atrial measurements: insights from the healthy hearts consortium
Doctor L. Szabo (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Native T1 is superior to ECV for cardiovascular risk assessment in an all-comer low-risk real-world clinical patient population
Doctor S. Backhaus (Bad Nauheim, DE)
Abstract Slides Video
Presentation thumbnail
Sub-clinical cardiac involvement, energetics, perfusion, and inflammation in early and late immune-mediated inflammatory diseases: a comparative study.
Professor S. Plein (Leeds, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Mapping and function in cardiac magnetic resonance

The Event

Event poster

ESC Congress 2025

30 August 2025 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Long-term cardiac pathology in individuals with mild initial COVID-19 illness
thumbnail
Congress Presentation
Individualised aerobic and resistance exercise training improves exercise tolerance in individuals with Long COVID: findings from the PERCEIVE randomised controlled trial
thumbnail
Congress Presentation
Cardiopulmonary long-term effects 6, 18 and 30 months after severe COVID-19 infection

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources